SB Aquafresh 17% Sales Increase Freshens Up Second Quarter Results
This article was originally published in The Tan Sheet
"Outstanding" U.S. activity by the Aquafresh brand in the second quarter contributed to a 17% spike in worldwide sales for the line and an 8% rise in global oral care sales to $255 mil., SmithKline Beecham CEO Jean-Paul Garnier, PhD, announced during a July 25 conference call.
You may also be interested in...
Avanir Pharmaceuticals' 10% docosanol cream was approved July 25 for the treatment of cold sores and fever blisters. The product, which FDA's approval letter indicates will be marketed as Abreva Cream, will be the first FDA-approved OTC cold sore and fever blister treatment.
SmithKline Beecham is moving its Aquafresh brand beyond the traditional dentrifice category into what appears to be the confectionary market.
The introduction of Clear NicoDerm CQ Patch will attract a substantial number of first-time users - especially among minority populations - to the smoking cessation category, marketer SmithKline Beecham predicted based on recent consumer research.